| Process consistency and product quality are key to | | | | p2000 system. ITS has invested in conducting a |
| the pharmaceutical industry from drug development | | | | pre-validation exercise with ABB Life Sciences. This |
| research through to manufacturing scale-up. To | | | | effectively tests the use of ITS technology against |
| ensure better quality and efficiency, the validation of | | | | criteria set out in GAMP 4 and also relates closely to |
| the equipment used to monitor and control these | | | | GAMP 5. |
| processes is crucial. Validation relates to | | | | The p2000 is able to help characterise complex |
| demonstrating that instrumentation has been tested | | | | processes such as crystallisation. As well as |
| and that the information reported corresponds to | | | | determining concentration variations through a vessel. |
| what is being measured. | | | | It is also able to provide information on key unit |
| Industrial Tomography Systems (ITS), as part of its | | | | processes such as mixing, filtration and liquid-liquid |
| commitment to working with the life science and | | | | separation. This offers the benefit of reducing batch |
| other regulated markets has introduced a validated | | | | cycle times and improving batch to batch consistency. |
| version of its popular electrical resistance tomography | | | | |